A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
Identifieur interne : 000E84 ( Main/Exploration ); précédent : 000E83; suivant : 000E85A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
Auteurs : Paul R. Womble [États-Unis] ; Susan M. Linsell [États-Unis] ; Yuqing Gao [États-Unis] ; Zaojun Ye [États-Unis] ; James E. Montie [États-Unis] ; Tejal N. Gandhi [États-Unis] ; Brian R. Lane [États-Unis] ; Frank N. Burks [États-Unis] ; David C. Miller [États-Unis]Source :
- The Journal of urology [ 1527-3792 ] ; 2015.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Adulte d'âge moyen (MeSH), Amélioration de la qualité (MeSH), Antibioprophylaxie (méthodes), Biopsie (effets indésirables), Biopsie (méthodes), Hospitalisation (tendances), Humains (MeSH), Incidence (MeSH), Infections bactériennes (prévention et contrôle), Infections bactériennes (épidémiologie), Infections bactériennes (étiologie), Maladies de la prostate (diagnostic), Michigan (épidémiologie), Mâle (MeSH), Prostate (anatomopathologie), Rectum (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Études de suivi (MeSH), Études rétrospectives (MeSH).
- MESH :
- anatomopathologie : Prostate.
- diagnostic : Maladies de la prostate.
- effets indésirables : Biopsie.
- méthodes : Antibioprophylaxie, Biopsie.
- prévention et contrôle : Infections bactériennes.
- tendances : Hospitalisation.
- épidémiologie : Infections bactériennes, Michigan.
- étiologie : Infections bactériennes.
- Adulte, Adulte d'âge moyen, Amélioration de la qualité, Humains, Incidence, Mâle, Rectum, Sujet âgé, Sujet âgé de 80 ans ou plus, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Antibiotic Prophylaxis (methods), Bacterial Infections (epidemiology), Bacterial Infections (etiology), Bacterial Infections (prevention & control), Biopsy (adverse effects), Biopsy (methods), Follow-Up Studies (MeSH), Hospitalization (trends), Humans (MeSH), Incidence (MeSH), Male (MeSH), Michigan (epidemiology), Middle Aged (MeSH), Prostate (pathology), Prostatic Diseases (diagnosis), Quality Improvement (MeSH), Rectum (MeSH), Retrospective Studies (MeSH).
- MESH :
- geographic , epidemiology : Michigan.
- adverse effects : Biopsy.
- diagnosis : Prostatic Diseases.
- epidemiology : Bacterial Infections.
- etiology : Bacterial Infections.
- methods : Antibiotic Prophylaxis, Biopsy.
- pathology : Prostate.
- prevention & control : Bacterial Infections.
- trends : Hospitalization.
- Adult, Aged, Aged, 80 and over, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Quality Improvement, Rectum, Retrospective Studies.
Abstract
PURPOSE
Recent data suggest that increasing rates of hospitalization after prostate biopsy are mainly due to infections from fluoroquinolone-resistant bacteria. We report the initial results of a statewide quality improvement intervention aimed at reducing infection related hospitalizations after transrectal prostate biopsy.
MATERIALS AND METHODS
From March 2012 through May 2014 data on patient demographics, comorbidities, prophylactic antibiotics and post-biopsy complications were prospectively entered into an electronic registry by trained abstractors in 30 practices participating in the MUSIC. During this period each practice implemented one or both of the interventions aimed at addressing fluoroquinolone resistance, namely 1) use of rectal swab culture directed antibiotics or 2) augmented antibiotic prophylaxis with a second agent in addition to standard fluoroquinolone therapy. We identified all patients with an infection related hospitalization within 30 days after biopsy and validated these events with claims data for a subset of patients. We then compared the frequency of infection related hospitalizations before (5,028 biopsies) and after (4,087 biopsies) implementation of the quality improvement intervention.
RESULTS
Overall the proportion of patients with infection related hospitalizations after prostate biopsy decreased by 53% from before to after implementation of the quality improvement intervention (1.19% before vs 0.56% after, p=0.002). Among post-implementation biopsies the rates of hospitalization were similar for patients receiving culture directed (0.47%) vs augmented (0.57%) prophylaxis. At a practice level the relative change in hospitalization rates varied from a 7.4% decrease to a 3.0% increase. Fourteen practices had no post-implementation hospitalizations.
CONCLUSIONS
A statewide intervention aimed at addressing fluoroquinolone resistance reduced post-prostate biopsy infection related hospitalizations in Michigan by 53%.
DOI: 10.1016/j.juro.2015.03.126
PubMed: 25896556
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.</title><author><name sortKey="Womble, Paul R" sort="Womble, Paul R" uniqKey="Womble P" first="Paul R" last="Womble">Paul R. Womble</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Linsell, Susan M" sort="Linsell, Susan M" uniqKey="Linsell S" first="Susan M" last="Linsell">Susan M. Linsell</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Gao, Yuqing" sort="Gao, Yuqing" uniqKey="Gao Y" first="Yuqing" last="Gao">Yuqing Gao</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Ye, Zaojun" sort="Ye, Zaojun" uniqKey="Ye Z" first="Zaojun" last="Ye">Zaojun Ye</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Montie, James E" sort="Montie, James E" uniqKey="Montie J" first="James E" last="Montie">James E. Montie</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Gandhi, Tejal N" sort="Gandhi, Tejal N" uniqKey="Gandhi T" first="Tejal N" last="Gandhi">Tejal N. Gandhi</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Division of Infectious Disease, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Lane, Brian R" sort="Lane, Brian R" uniqKey="Lane B" first="Brian R" last="Lane">Brian R. Lane</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Spectrum Health Medical Group, Grand Rapids, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, Spectrum Health Medical Group, Grand Rapids</wicri:cityArea></affiliation></author><author><name sortKey="Burks, Frank N" sort="Burks, Frank N" uniqKey="Burks F" first="Frank N" last="Burks">Frank N. Burks</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak</wicri:cityArea></affiliation></author><author><name sortKey="Miller, David C" sort="Miller, David C" uniqKey="Miller D" first="David C" last="Miller">David C. Miller</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan. Electronic address: dcmiller@med.umich.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25896556</idno><idno type="pmid">25896556</idno><idno type="doi">10.1016/j.juro.2015.03.126</idno><idno type="wicri:Area/Main/Corpus">000E03</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000E03</idno><idno type="wicri:Area/Main/Curation">000E03</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000E03</idno><idno type="wicri:Area/Main/Exploration">000E03</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.</title><author><name sortKey="Womble, Paul R" sort="Womble, Paul R" uniqKey="Womble P" first="Paul R" last="Womble">Paul R. Womble</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Linsell, Susan M" sort="Linsell, Susan M" uniqKey="Linsell S" first="Susan M" last="Linsell">Susan M. Linsell</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Gao, Yuqing" sort="Gao, Yuqing" uniqKey="Gao Y" first="Yuqing" last="Gao">Yuqing Gao</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Ye, Zaojun" sort="Ye, Zaojun" uniqKey="Ye Z" first="Zaojun" last="Ye">Zaojun Ye</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Montie, James E" sort="Montie, James E" uniqKey="Montie J" first="James E" last="Montie">James E. Montie</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Gandhi, Tejal N" sort="Gandhi, Tejal N" uniqKey="Gandhi T" first="Tejal N" last="Gandhi">Tejal N. Gandhi</name><affiliation wicri:level="2"><nlm:affiliation>Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Division of Infectious Disease, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author><author><name sortKey="Lane, Brian R" sort="Lane, Brian R" uniqKey="Lane B" first="Brian R" last="Lane">Brian R. Lane</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Spectrum Health Medical Group, Grand Rapids, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, Spectrum Health Medical Group, Grand Rapids</wicri:cityArea></affiliation></author><author><name sortKey="Burks, Frank N" sort="Burks, Frank N" uniqKey="Burks F" first="Frank N" last="Burks">Frank N. Burks</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak</wicri:cityArea></affiliation></author><author><name sortKey="Miller, David C" sort="Miller, David C" uniqKey="Miller D" first="David C" last="Miller">David C. Miller</name><affiliation wicri:level="2"><nlm:affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan. Electronic address: dcmiller@med.umich.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Department of Urology, University of Michigan, Ann Arbor</wicri:cityArea></affiliation></author></analytic><series><title level="j">The Journal of urology</title><idno type="eISSN">1527-3792</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Antibiotic Prophylaxis (methods)</term><term>Bacterial Infections (epidemiology)</term><term>Bacterial Infections (etiology)</term><term>Bacterial Infections (prevention & control)</term><term>Biopsy (adverse effects)</term><term>Biopsy (methods)</term><term>Follow-Up Studies (MeSH)</term><term>Hospitalization (trends)</term><term>Humans (MeSH)</term><term>Incidence (MeSH)</term><term>Male (MeSH)</term><term>Michigan (epidemiology)</term><term>Middle Aged (MeSH)</term><term>Prostate (pathology)</term><term>Prostatic Diseases (diagnosis)</term><term>Quality Improvement (MeSH)</term><term>Rectum (MeSH)</term><term>Retrospective Studies (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Amélioration de la qualité (MeSH)</term><term>Antibioprophylaxie (méthodes)</term><term>Biopsie (effets indésirables)</term><term>Biopsie (méthodes)</term><term>Hospitalisation (tendances)</term><term>Humains (MeSH)</term><term>Incidence (MeSH)</term><term>Infections bactériennes (prévention et contrôle)</term><term>Infections bactériennes (épidémiologie)</term><term>Infections bactériennes (étiologie)</term><term>Maladies de la prostate (diagnostic)</term><term>Michigan (épidémiologie)</term><term>Mâle (MeSH)</term><term>Prostate (anatomopathologie)</term><term>Rectum (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Études de suivi (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Michigan</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Biopsy</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Prostate</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Prostatic Diseases</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Maladies de la prostate</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Bacterial Infections</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Bacterial Infections</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Antibiotic Prophylaxis</term><term>Biopsy</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Antibioprophylaxie</term><term>Biopsie</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Prostate</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Bacterial Infections</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections bactériennes</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Hospitalisation</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections bactériennes</term><term>Michigan</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Infections bactériennes</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Follow-Up Studies</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Quality Improvement</term><term>Rectum</term><term>Retrospective Studies</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Amélioration de la qualité</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Rectum</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études de suivi</term><term>Études rétrospectives</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b></p><p>Recent data suggest that increasing rates of hospitalization after prostate biopsy are mainly due to infections from fluoroquinolone-resistant bacteria. We report the initial results of a statewide quality improvement intervention aimed at reducing infection related hospitalizations after transrectal prostate biopsy.</p></div><div type="abstract" xml:lang="en"><p><b>MATERIALS AND METHODS</b></p><p>From March 2012 through May 2014 data on patient demographics, comorbidities, prophylactic antibiotics and post-biopsy complications were prospectively entered into an electronic registry by trained abstractors in 30 practices participating in the MUSIC. During this period each practice implemented one or both of the interventions aimed at addressing fluoroquinolone resistance, namely 1) use of rectal swab culture directed antibiotics or 2) augmented antibiotic prophylaxis with a second agent in addition to standard fluoroquinolone therapy. We identified all patients with an infection related hospitalization within 30 days after biopsy and validated these events with claims data for a subset of patients. We then compared the frequency of infection related hospitalizations before (5,028 biopsies) and after (4,087 biopsies) implementation of the quality improvement intervention.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Overall the proportion of patients with infection related hospitalizations after prostate biopsy decreased by 53% from before to after implementation of the quality improvement intervention (1.19% before vs 0.56% after, p=0.002). Among post-implementation biopsies the rates of hospitalization were similar for patients receiving culture directed (0.47%) vs augmented (0.57%) prophylaxis. At a practice level the relative change in hospitalization rates varied from a 7.4% decrease to a 3.0% increase. Fourteen practices had no post-implementation hospitalizations.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>A statewide intervention aimed at addressing fluoroquinolone resistance reduced post-prostate biopsy infection related hospitalizations in Michigan by 53%.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25896556</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3792</ISSN><JournalIssue CitedMedium="Internet"><Volume>194</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of urology</Title><ISOAbbreviation>J Urol</ISOAbbreviation></Journal><ArticleTitle>A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.</ArticleTitle><Pagination><MedlinePgn>403-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.juro.2015.03.126</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5347(15)03828-8</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Recent data suggest that increasing rates of hospitalization after prostate biopsy are mainly due to infections from fluoroquinolone-resistant bacteria. We report the initial results of a statewide quality improvement intervention aimed at reducing infection related hospitalizations after transrectal prostate biopsy.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">From March 2012 through May 2014 data on patient demographics, comorbidities, prophylactic antibiotics and post-biopsy complications were prospectively entered into an electronic registry by trained abstractors in 30 practices participating in the MUSIC. During this period each practice implemented one or both of the interventions aimed at addressing fluoroquinolone resistance, namely 1) use of rectal swab culture directed antibiotics or 2) augmented antibiotic prophylaxis with a second agent in addition to standard fluoroquinolone therapy. We identified all patients with an infection related hospitalization within 30 days after biopsy and validated these events with claims data for a subset of patients. We then compared the frequency of infection related hospitalizations before (5,028 biopsies) and after (4,087 biopsies) implementation of the quality improvement intervention.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall the proportion of patients with infection related hospitalizations after prostate biopsy decreased by 53% from before to after implementation of the quality improvement intervention (1.19% before vs 0.56% after, p=0.002). Among post-implementation biopsies the rates of hospitalization were similar for patients receiving culture directed (0.47%) vs augmented (0.57%) prophylaxis. At a practice level the relative change in hospitalization rates varied from a 7.4% decrease to a 3.0% increase. Fourteen practices had no post-implementation hospitalizations.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A statewide intervention aimed at addressing fluoroquinolone resistance reduced post-prostate biopsy infection related hospitalizations in Michigan by 53%.</AbstractText><CopyrightInformation>Copyright © 2015 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Womble</LastName><ForeName>Paul R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linsell</LastName><ForeName>Susan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yuqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Zaojun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montie</LastName><ForeName>James E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gandhi</LastName><ForeName>Tejal N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Division of Infectious Disease, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Department of Urology, Spectrum Health Medical Group, Grand Rapids, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burks</LastName><ForeName>Frank N</ForeName><Initials>FN</Initials><AffiliationInfo><Affiliation>Department of Urology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Urology, University of Michigan, Ann Arbor, Michigan. Electronic address: dcmiller@med.umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Michigan Urological Surgery Improvement Collaborative</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Urol</MedlineTA><NlmUniqueID>0376374</NlmUniqueID><ISSNLinking>0022-5347</ISSNLinking></MedlineJournalInfo><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="N">Antibiotic Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008824" MajorTopicYN="N" Type="Geographic">Michigan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011467" MajorTopicYN="N">Prostate</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011469" MajorTopicYN="N">Prostatic Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="Y">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012007" MajorTopicYN="N">Rectum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-bacterial agents</Keyword><Keyword MajorTopicYN="N">biopsy</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">prostate</Keyword><Keyword MajorTopicYN="N">quality improvement</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>03</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25896556</ArticleId><ArticleId IdType="pii">S0022-5347(15)03828-8</ArticleId><ArticleId IdType="doi">10.1016/j.juro.2015.03.126</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Michigan</li></region></list><tree><country name="États-Unis"><region name="Michigan"><name sortKey="Womble, Paul R" sort="Womble, Paul R" uniqKey="Womble P" first="Paul R" last="Womble">Paul R. Womble</name></region><name sortKey="Burks, Frank N" sort="Burks, Frank N" uniqKey="Burks F" first="Frank N" last="Burks">Frank N. Burks</name><name sortKey="Gandhi, Tejal N" sort="Gandhi, Tejal N" uniqKey="Gandhi T" first="Tejal N" last="Gandhi">Tejal N. Gandhi</name><name sortKey="Gao, Yuqing" sort="Gao, Yuqing" uniqKey="Gao Y" first="Yuqing" last="Gao">Yuqing Gao</name><name sortKey="Lane, Brian R" sort="Lane, Brian R" uniqKey="Lane B" first="Brian R" last="Lane">Brian R. Lane</name><name sortKey="Linsell, Susan M" sort="Linsell, Susan M" uniqKey="Linsell S" first="Susan M" last="Linsell">Susan M. Linsell</name><name sortKey="Miller, David C" sort="Miller, David C" uniqKey="Miller D" first="David C" last="Miller">David C. Miller</name><name sortKey="Montie, James E" sort="Montie, James E" uniqKey="Montie J" first="James E" last="Montie">James E. Montie</name><name sortKey="Ye, Zaojun" sort="Ye, Zaojun" uniqKey="Ye Z" first="Zaojun" last="Ye">Zaojun Ye</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SanteMusiqueV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E84 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E84 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SanteMusiqueV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25896556
|texte= A Statewide Intervention to Reduce Hospitalizations after Prostate Biopsy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25896556" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SanteMusiqueV1
| This area was generated with Dilib version V0.6.38. |  |